Dose Escalation TTHX1114 Ophthalmic Solution

Clinical trial NCT05769920 · COMPLETED

Trial details

NCT number: NCT05769920
Sponsor: Trefoil Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Corneal Epithelial Degeneration

Start date: 2022-12-06
Primary completion: 2023-04-12
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.